Autolus Therapeutics plc (AUTL)
USD 2.29
(-8.03%)
USD 2.29
(-8.03%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.69 Million | 6.19 Million | 2.33 Million | 242 Thousand | 2.9 Million | 1.04 Million |
| Cost of Revenue | 6.56 Million | 137.22 Million | 128.65 Million | 134.88 Million | 4.61 Million | 48.29 Million |
| Gross Profit | -4.86 Million | -131.02 Million | -126.32 Million | -134.64 Million | -1.7 Million | -47.25 Million |
| Operating Expenses | 196.72 Million | 173.72 Million | 166.65 Million | 168.38 Million | 144.87 Million | 41.48 Million |
| Selling, General and Administrative Expenses | 46.74 Million | 31.89 Million | 31.86 Million | 34.97 Million | 39.45 Million | 16.84 Million |
| Research and Development Expenses | 149.98 Million | 141.99 Million | 134.78 Million | 134.88 Million | 105.41 Million | 24.63 Million |
| Other Expenses | - | -166 Thousand | -145 Thousand | -1.47 Million | 4.51 Million | 3.97 Million |
| Cost and Expenses | 196.72 Million | 173.72 Million | 166.65 Million | 168.38 Million | 144.87 Million | 41.48 Million |
| Operating Income | -195.02 Million | -163.78 Million | -164.2 Million | -168.14 Million | -137.86 Million | -57.53 Million |
| Interest Expense | 45.06 Million | 8.9 Million | 1.1 Million | - | - | 12.66 Thousand |
| Income Tax Expense | -19 Thousand | -24.36 Million | -23.89 Million | -24.16 Million | -15.15 Million | -5.21 Million |
| Earnings before Tax | -208.4 Million | -173.2 Million | -165.98 Million | -166.25 Million | -139 Million | -36.32 Million |
| Net Income | -208.38 Million | -148.83 Million | -142.09 Million | -142.09 Million | -123.84 Million | -31.11 Million |
| Earnings Per Share Basic | -1.20 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 |
| Earnings Per Share Diluted | -1.20 | -1.57 | -1.97 | -2.76 | -2.88 | -0.99 |
| Weighted Average Shares Outstanding | 173.94 Million | 94.99 Million | 72.08 Million | 51.55 Million | 43.06 Million | 31.55 Million |
| Weighted Average Shares Outstanding (Diluted) | 173.94 Million | 94.99 Million | 72.08 Million | 51.55 Million | 43.06 Million | 31.55 Million |
| Gross Margin | -2.87 | -21.15 | -54.22 | -556.39 | -0.59 | -45.20 |
| EBIT Margin | -92.33 | -25.24 | -66.85 | -671.43 | -45.82 | -33.68 |
| Profit Margin | -122.72 | -24.03 | -60.99 | -587.17 | -42.59 | -29.76 |
| EBITDA | -156.77 Million | -135.53 Million | -132 Million | -160.5 Million | -134.39 Million | -50.32 Million |
| Earnings Before Tax Margin | -114.86 | -26.44 | -70.48 | -694.81 | -47.41 | -55.04 |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | 10.09 Million | 1.77 Million | 1.69 Million | 406 Thousand | - |
| Cost of Revenue | 1.89 Million | 1.8 Million | 1.77 Million | 6.56 Million | 382 Thousand | 1.51 Million |
| Gross Profit | -1.89 Million | 8.28 Million | - | -4.86 Million | 24 Thousand | -1.51 Million |
| Operating Expenses | 56.62 Million | 47.04 Million | 39.11 Million | 190.16 Million | 47.84 Million | 47.86 Million |
| Selling, General and Administrative Expenses | 20 Million | 16.37 Million | 13.95 Million | - | 10.61 Million | 11.12 Million |
| Research and Development Expenses | 36.61 Million | 30.67 Million | 25.15 Million | - | 37.23 Million | 36.74 Million |
| Other Expenses | 1.22 Million | -1.6 Million | 3.19 Million | -19.5 Million | -1.59 Million | 482 Thousand |
| Cost and Expenses | 58.51 Million | 48.84 Million | 40.88 Million | 177.22 Million | 47.84 Million | 47.86 Million |
| Operating Income | -58.51 Million | -38.75 Million | -40.88 Million | -195.02 Million | -48.23 Million | -43.97 Million |
| Interest Expense | 10.17 Million | 19.26 Million | 30.12 Million | 45.06 Million | 5.01 Million | 5.02 Million |
| Income Tax Expense | 51 Thousand | -8000.00 | 12.36 Million | -19 Thousand | -4.94 Million | -3.47 Million |
| Earnings before Tax | -58.22 Million | -52.69 Million | -64.81 Million | -208.4 Million | -50.78 Million | -49.02 Million |
| Net Income | -58.27 Million | -52.69 Million | -77.17 Million | -208.38 Million | -45.84 Million | -45.55 Million |
| Earnings Per Share Basic | -0.22 | -0.24 | -0.44 | - | -0.26 | -0.26 |
| Earnings Per Share Diluted | -0.22 | -0.24 | -0.44 | - | -0.26 | -0.26 |
| Weighted Average Shares Outstanding | 266.02 Million | 222.17 Million | 174.02 Million | 173.94 Million | 173.98 Million | 173.86 Million |
| Weighted Average Shares Outstanding (Diluted) | 266.02 Million | 222.17 Million | 174.02 Million | 173.94 Million | 173.98 Million | 173.86 Million |
| Gross Margin | - | 0.82 | - | -2.87 | 0.06 | - |
| EBIT Margin | - | -3.66 | -22.03 | - | -108.41 | - |
| Profit Margin | - | -5.22 | -43.48 | -122.72 | -112.93 | - |
| EBITDA | -56.62 Million | -36.95 Million | -39.11 Million | - | -44.01 Million | -42.46 Million |
| Earnings Before Tax Margin | - | -3.84 | -23.03 | -114.86 | -118.79 | - |
WSP
SKHSF
460940
601009
CWIR
5715